Vertex Pharmaceuticals Incorporated (LON:0QZU)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	87,090	82,838	82,315	61,522	41,234	45,014
Market Cap Growth	3.12%	0.64%	33.80%	49.20%	-8.40%	5.89%
Enterprise Value	79,516	75,287	72,200	54,097	36,741	40,909
Last Close Price	347.50	320.91	319.55	236.58	163.63	171.91
PE Ratio	31.85	-	28.97	22.31	23.84	22.66
PS Ratio	9.99	9.41	10.62	8.30	7.37	9.90
PB Ratio	6.76	6.32	5.96	5.33	5.53	7.08
P/TBV Ratio	7.41	7.15	6.70	6.07	6.42	8.44
P/FCF Ratio	35.08	-	31.42	18.89	23.18	20.53
P/OCF Ratio	31.49	-	29.64	17.95	21.12	18.89
EV/Sales Ratio	9.11	8.55	9.32	7.30	6.57	9.00
EV/EBITDA Ratio	21.80	20.59	20.54	14.40	12.38	17.66
EV/EBIT Ratio	23.55	21.45	21.35	14.89	12.78	18.29
EV/FCF Ratio	32.03	-	27.56	16.61	20.66	18.66
Debt / Equity Ratio	0.11	0.11	0.05	0.07	0.10	0.11
Debt / EBITDA Ratio	0.37	0.37	0.18	0.20	0.24	0.30
Debt / FCF Ratio	0.55	-	0.24	0.23	0.40	0.32
Asset Turnover	0.50	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	4.10	5.31	7.38	8.87	8.97	10.62
Quick Ratio	1.84	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.36	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	22.31%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	12.04%	12.14%	13.17%	17.33%	19.32%	19.02%
Return on Invested Capital (ROIC)	29.76%	-98.60%	63.54%	90.72%	102.53%	89.76%
Return on Capital Employed (ROCE)	22.30%	23.20%	22.50%	28.40%	34.50%	30.90%
Earnings Yield	3.14%	-0.52%	3.45%	4.48%	4.20%	4.41%
FCF Yield	2.85%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	-0.11%	1.00%	-0.54%	0.31%	1.33%	-1.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.